Microdissected tumors and associated ductal hyperplastic tissue from 37 patients for K-ras mutation and X-chromosome inactivation analyses demonstrated distinct genomic abnormalities in hyperplasia as well as pancreatic cancer. Here, KRAS is linked to familial pancreatic carcinoma.